Credit Suisse’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Credit Suisse’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-32,350	Closed	-$1.89M	–	4907
2013 Q4	$1.89M	Buy	+32,350	New	+$1.69M	﹤0.01%	2696

Credit Suisse's ARNA Position: Q1 2022 in Review

Credit Suisse sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 250,553 shares — an estimated $23.3M sold.

Credit Suisse first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $65.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Credit Suisse reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Credit Suisse sold 250,553 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $23.3M.
Credit Suisse first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
Credit Suisse's Arena Pharmaceuticals Inc position peaked at $65.6M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.